Singapore, March 6 -- SK Chemicals, which developed Korea's first herbal medicine product for osteoarthritis, Joins, has expanded its pain management portfolio. The company has signed a distribution and promotional service agreement with Viatris Korea for Celebrex, Lyrica, and Neurontin.

Under the Agreement, SK Chemicals will manage distribution to all hospitals and to Viatris' full customer base for these three pharmaceuticals. The company will also support marketing in hospitals and clinics with fewer than 300 hospital beds, while Viatris will manage marketing in hospitals with 300 or more beds.

Celebrex, an anti-inflammatory analgesic drug, Lyrica, a treatment for peripheral and central neuropathic pain, and Neurontin, a neuropathic ...